Trade receivables increased 24.3%
Trade receivables changed +24.3% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$98.5M→$122.4M4 prior comparisons
GROSSPATTERN / DETERMINISTIC EVIDENCE / V3
Search securities →NCNO financial changes
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Capital expenditure decreased 96.2%
Capital expenditure changed -96.2% from the comparable as-filed period.
$5.1M→$195,0003 prior comparisons
Net income changed across a sign change
Net income changed +133.3% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
-$15.3M→$5.1M2 prior comparisons
R&D / revenue moved 402 bp lower
R&D / revenue changed -402 basis points from the comparable as-filed period.
23.30%→19.27%2 prior comparisons
Receivables / revenue moved 983 bp higher
Receivables / revenue changed +983 basis points from the comparable as-filed period.
66.17%→76.00%2 prior comparisons
Revenue increased 8.2%
Revenue changed +8.2% from the comparable as-filed period.
$148.8M→$161.0M2 prior comparisons
Current liabilities increased 15.3%
Current liabilities changed +15.3% from the comparable as-filed period. The change ranks at the 25th percentile of 4 prior comparable changes.
$248.6M→$286.8M4 prior comparisons
Free-cash-flow margin moved 1266 bp higher
Free-cash-flow margin changed +1266 basis points from the comparable as-filed period.
8.46%→21.12%2 prior comparisons
Operating cash-flow margin moved 932 bp higher
Operating cash-flow margin changed +932 basis points from the comparable as-filed period.
11.92%→21.24%2 prior comparisons
Gross profit increased 14.4%
Gross profit changed +14.4% from the comparable as-filed period.
$88.1M→$100.8M2 prior comparisons
SBC / revenue moved 133 bp lower
SBC / revenue changed -133 basis points from the comparable as-filed period.
12.51%→11.18%2 prior comparisons
Research & development decreased 10.5%
Research & development changed -10.5% from the comparable as-filed period.
$34.7M→$31.0M2 prior comparisons
Current assets decreased 4.8%
Current assets changed -4.8% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$255.1M→$242.9M4 prior comparisons
Total assets decreased 2.7%
Total assets changed -2.7% from the comparable as-filed period. The change ranks at the 50th percentile of 4 prior comparable changes.
$1.6B→$1.6B4 prior comparisons
Stock-based compensation decreased 3.3%
Stock-based compensation changed -3.3% from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
$18.6M→$18.0M2 prior comparisons
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.